The current Flagship ecosystem comprises 41 transformative companies, including: Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS). Other responsibilities include assessing biological, clinical, and commercial hypotheses of product concepts, performing deep dives and diligence of potential programs, and generating competitive and landscape analyses of therapeutic areas, some of which may be completed in cross-functional collaborations with other teams and functions within the broader Product & Partnering team and Flagship ecosystem.